TIM-LAT Trademark

Trademark Overview

On Thursday, February 9, 2017, a trademark application was filed for TIM-LAT with the United States Patent and Trademark Office. The USPTO has given the TIM-LAT trademark a serial number of 87329876. The federal status of this trademark filing is REGISTERED as of Tuesday, August 14, 2018. This trademark is owned by IMPRIMIS PHARMACEUTICALS, INC.. The TIM-LAT trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical compositions for ophthalmological use
tim-lat

General Information

Serial Number87329876
Word MarkTIM-LAT
Filing DateThursday, February 9, 2017
Status700 - REGISTERED
Status DateTuesday, August 14, 2018
Registration Number5542813
Registration DateTuesday, August 14, 2018
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements

Goods and ServicesPharmaceutical compositions for ophthalmological use

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, February 14, 2017
Primary Code005
First Use Anywhere DateWednesday, February 1, 2017
First Use In Commerce DateWednesday, February 1, 2017

Trademark Owner History

Party NameHARROW IP, LLC
Party Type32 - New Owner After Registration
Legal Entity Type16 - Limited Liability Company
AddressNashville, TN 37205
Party NameHARROW HEALTH, INC.
Party Type31 - New Owner After Registration
Legal Entity Type03 - Corporation
AddressSAN DIEGO, CA 92130
Party NameIMPRIMIS PHARMACEUTICALS, INC.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressSan Diego, CA 92130
Party NameIMPRIMIS PHARMACEUTICALS, INC.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSan Diego, CA 92130

Trademark Events

Event DateEvent Description
Monday, August 14, 2023COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Wednesday, April 12, 2023ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
Wednesday, December 16, 2020APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Wednesday, December 16, 2020TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, December 16, 2020ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, December 16, 2020TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, December 16, 2020TEAS CHANGE OF OWNER ADDRESS RECEIVED
Tuesday, October 27, 2020TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, October 27, 2020ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, October 27, 2020TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Monday, September 14, 2020APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Monday, September 14, 2020TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, September 14, 2020TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Monday, September 14, 2020ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, September 14, 2020TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Monday, September 14, 2020TEAS CHANGE OF OWNER ADDRESS RECEIVED
Wednesday, November 27, 2019ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
Wednesday, November 6, 2019AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Wednesday, January 16, 2019AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Tuesday, August 14, 2018REGISTERED-SUPPLEMENTAL REGISTER
Saturday, June 2, 2018LAW OFFICE PUBLICATION REVIEW COMPLETED
Thursday, May 31, 2018ASSIGNED TO LIE
Friday, May 18, 2018NOTICE OF ACCEPTANCE OF AMENDMENT TO ALLEGE USE E-MAILED
Thursday, May 17, 2018APPROVED FOR REGISTRATION SUPPLEMENTAL REGISTER
Thursday, May 17, 2018USE AMENDMENT ACCEPTED
Saturday, May 12, 2018TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, May 11, 2018CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, May 11, 2018TEAS REQUEST FOR RECONSIDERATION RECEIVED
Saturday, May 12, 2018AMENDMENT TO USE PROCESSING COMPLETE
Saturday, May 12, 2018USE AMENDMENT FILED
Friday, May 11, 2018TEAS AMENDMENT OF USE RECEIVED
Tuesday, December 5, 2017NOTIFICATION OF FINAL REFUSAL EMAILED
Tuesday, December 5, 2017FINAL REFUSAL E-MAILED
Tuesday, December 5, 2017FINAL REFUSAL WRITTEN
Tuesday, November 14, 2017TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, November 14, 2017CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, November 13, 2017ASSIGNED TO LIE
Tuesday, October 31, 2017TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, May 8, 2017NOTIFICATION OF PRIORITY ACTION E-MAILED
Monday, May 8, 2017PRIORITY ACTION E-MAILED
Monday, May 8, 2017PRIORITY ACTION WRITTEN
Wednesday, May 3, 2017ASSIGNED TO EXAMINER
Tuesday, February 14, 2017NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, February 13, 2017NEW APPLICATION ENTERED

Related Keywords

ophthalmological compositions pharmaceutical